4 research outputs found
Π―Π·Π²Ρ ΠΠ°ΡΡΠΎΡΠ΅Π»Π»Π°
There is description in the article of a case of hypertensive ulcer pathology of legs or Martorellβs ulcers diagnostics, which are complications of long-standing and poor-controlled essential hypertension. The patient 42 years old male presented with complaints of long-standing, non-healing and painful ulcer on the left leg, sustained blood pressure elevation (up to 230/120 mm Hg). History disease revealed blood pressure elevations since 16 years old age, but the patient sought medical advice extremely seldom and did not take antihypertensive treatment in fact. He noted when was 35 years old a painful ulcer located on anterolateral surface of the leg. Concerning it he treated by himself unsuccessfully and then β in differ ent health care centers. The condition deteriorated in 2016, when ulcer defect become larger and more painful. On admission at examination the ulcer of oval shape (size 7 Γ 4 cm and depth 0.6 cm) on anterolateral surface of the lower third of left leg is present. In clinical and biochemistry analyses no pathology was found. There were signs of left ventricle hypertrophy on the data of electroand echocardiographic inves tigations. No alterations during complex ultrasound examination of vessels of both lower extremities were revealed. Examination of angiosurgeon: no pathology. With the purpose to diagnosis specification path omorphologic study of tissue fragments of injured zone was performed. The results of this study showed that revealed changes are relevant for hypertensive ulcers of legs or Martorellβs ulcers. The presented case illustrates the necessity of more broad informing medical community about possibility of incidence of Martorellβs ulcers that in turn assumes application of adequate measures of local treat ment, including dermatoplasty, and effective antihypertensive therapy.Π ΡΡΠ°ΡΡΠ΅ ΠΏΡΠΈΠ²ΠΎΠ΄ΠΈΡΡΡ ΠΎΠΏΠΈΡΠ°Π½ΠΈΠ΅ ΡΠ»ΡΡΠ°Ρ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ Π³ΠΈΠΏΠ΅ΡΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠ·Π² Π½ΠΈΠΆΠ½ΠΈΡ
ΠΊΠΎΠ½Π΅ΡΠ½ΠΎΡΡΠ΅ΠΉ, ΠΈΠ»ΠΈ ΡΠ·Π² ΠΠ°ΡΡΠΎΡΠ΅Π»Π»Π° (Π―Π), ΡΠ²ΠΈΠ²ΡΠΈΡ
ΡΡ ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΠ΅ΠΌ Π΄Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ ΠΈ ΠΏΠ»ΠΎΡ
ΠΎ ΠΊΠΎΠ½ΡΡΠΎΠ»ΠΈΡΡΠ΅ΠΌΠΎΠΉ Π³ΠΈΠΏΠ΅ΡΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ Π±ΠΎΠ»Π΅Π·Π½ΠΈ. ΠΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½ Π±ΠΎΠ»ΡΠ½ΠΎΠΉ 42 Π»Π΅Ρ Ρ ΠΆΠ°Π»ΠΎΠ±Π°ΠΌΠΈ Π½Π° Π΄Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎ Π½Π΅ Π·Π°ΠΆΠΈΠ²Π°ΡΡΡΡ, Π±ΠΎΠ»Π΅Π·Π½Π΅Π½Π½ΡΡ ΡΠ·Π²Ρ Π½Π° Π»Π΅Π²ΠΎΠΉ Π³ΠΎΠ»Π΅Π½ΠΈ, ΡΡΠΎΠΉΠΊΠΎΠ΅ ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΠ΅ Π°ΡΡΠ΅ΡΠΈΠ°Π»ΡΠ½ΠΎΠ³ΠΎ Π΄Π°Π²Π»Π΅Π½ΠΈΡ (Π΄ΠΎ 230/120 ΠΌΠΌ ΡΡ. ΡΡ.). ΠΠ· Π°Π½Π°ΠΌΠ½Π΅Π·Π° Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ ΠΈΠ·Π²Π΅ΡΡΠ½ΠΎ, ΡΡΠΎ ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΠ΅ ΠΠ ΠΎΡΠΌΠ΅ΡΠ°Π΅Ρ Ρ 16-Π»Π΅ΡΠ½Π΅Π³ΠΎ Π²ΠΎΠ·ΡΠ°ΡΡΠ°, ΠΎΠ΄Π½Π°ΠΊΠΎ Π·Π° ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΎΠΉ ΠΏΠΎΠΌΠΎΡΡΡ ΠΎΠ±ΡΠ°ΡΠ°Π»ΡΡ ΠΊΡΠ°ΠΉΠ½Π΅ ΡΠ΅Π΄ΠΊΠΎ, Π°Π½ΡΠΈΠ³ΠΈΠΏΠ΅ΡΡΠ΅Π½Π·ΠΈΠ²Π½ΡΡ ΡΠ΅ΡΠ°ΠΏΠΈΡ ΡΠ°ΠΊΡΠΈΡΠ΅ΡΠΊΠΈ Π½Π΅ ΠΏΡΠΈΠ½ΠΈΠΌΠ°Π». Π Π²ΠΎΠ·ΡΠ°ΡΡΠ΅ 35 Π»Π΅Ρ ΠΎΠ±Π½Π°ΡΡΠΆΠΈΠ» Π±ΠΎΠ»Π΅Π·Π½Π΅Π½Π½ΡΡ ΡΠ·Π²Ρ Π½Π° Π½ΠΈΠΆΠ½Π΅ΠΉ ΡΡΠ΅ΡΠΈ ΠΏΠ΅ΡΠ΅Π΄Π½Π΅Π»Π°ΡΠ΅ΡΠ°Π»ΡΠ½ΠΎΠΉ ΠΏΠΎΠ²Π΅ΡΡ
Π½ΠΎΡΡΠΈ Π³ΠΎΠ»Π΅Π½ΠΈ, ΠΊΠΎΡΠΎΡΡΡ Π±Π΅Π·ΡΡΠΏΠ΅ΡΠ½ΠΎ Π»Π΅ΡΠΈΠ» ΡΠ°ΠΌΠΎΡΡΠΎΡΡΠ΅Π»ΡΠ½ΠΎ, Π° Π΄Π°Π»Π΅Π΅ β Π² ΡΠ°Π·Π»ΠΈΡΠ½ΡΡ
Π»Π΅ΡΠ΅Π±Π½ΡΡ
ΡΡΡΠ΅ΠΆΠ΄Π΅Π½ΠΈΡΡ
. Π‘ΠΎΡΡΠΎΡΠ½ΠΈΠ΅ ΡΡ
ΡΠ΄ΡΠΈΠ»ΠΎΡΡ Π² 2016 Π³., ΠΊΠΎΠ³Π΄Π° ΡΠ·Π²Π΅Π½Π½ΡΠΉ Π΄Π΅ΡΠ΅ΠΊΡ ΡΠ²Π΅Π»ΠΈΡΠΈΠ»ΡΡ Π² ΡΠ°Π·ΠΌΠ΅ΡΠ°Ρ
, ΡΡΠ°Π» ΡΠ΅Π·ΠΊΠΎ Π±ΠΎΠ»Π΅Π·Π½Π΅Π½Π½ΡΠΌ. ΠΡΠΈ ΠΎΡΠΌΠΎΡΡΠ΅ Π² ΠΌΠΎΠΌΠ΅Π½Ρ ΠΏΠΎΡΡΡΠΏΠ»Π΅Π½ΠΈΡ Π² ΠΊΠ»ΠΈΠ½ΠΈΠΊΡ ΠΎΡΠΌΠ΅ΡΠ°Π΅ΡΡΡ ΡΠ·Π²Π° ΠΎΠ²Π°Π»ΡΠ½ΠΎΠΉ ΡΠΎΡΠΌΡ ΡΠ°Π·ΠΌΠ΅ΡΠΎΠΌ 7 Γ 4 ΡΠΌ ΠΈ Π³Π»ΡΠ±ΠΈΠ½ΠΎΠΉ 0,6 ΡΠΌ Π½Π° ΠΏΠ΅ΡΠ΅Π΄Π½Π΅Π»Π°ΡΠ΅ΡΠ°Π»ΡΠ½ΠΎΠΉ ΠΏΠΎΠ²Π΅ΡΡ
Π½ΠΎΡΡΠΈ Π½ΠΈΠΆΠ½Π΅ΠΉ ΡΡΠ΅ΡΠΈ Π»Π΅Π²ΠΎΠΉ Π³ΠΎΠ»Π΅Π½ΠΈ. Π ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΈ Π±ΠΈΠΎΡ
ΠΈΠΌΠΈΡΠ΅ΡΠΊΠΈΡ
Π°Π½Π°Π»ΠΈΠ·Π°Ρ
ΠΊΡΠΎΠ²ΠΈ ΠΈ ΠΌΠΎΡΠΈ β Π±Π΅Π· ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΠΈ. ΠΠ° ΡΠ»Π΅ΠΊΡΡΠΎΠΈ ΡΡ
ΠΎΠΊΠ°ΡΠ΄ΠΈΠΎΠ³ΡΠ°ΠΌΠΌΠ΅ β ΠΏΡΠΈΠ·Π½Π°ΠΊΠΈ Π³ΠΈΠΏΠ΅ΡΡΡΠΎΡΠΈΠΈ Π»Π΅Π²ΠΎΠ³ΠΎ ΠΆΠ΅Π»ΡΠ΄ΠΎΡΠΊΠ°. ΠΡΠΈ ΠΊΠΎΠΌΠΏΠ»Π΅ΠΊΡΠ½ΠΎΠΌ ΡΠ»ΡΡΡΠ°Π·Π²ΡΠΊΠΎΠ²ΠΎΠΌ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΈ ΡΠΎΡΡΠ΄ΠΎΠ² Π½ΠΈΠΆΠ½ΠΈΡ
ΠΊΠΎΠ½Π΅ΡΠ½ΠΎΡΡΠ΅ΠΉ ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠΉ Π½Π΅ Π²ΡΡΠ²Π»Π΅Π½ΠΎ. ΠΡΠΌΠΎΡΡ Π°Π½Π³ΠΈΠΎΡ
ΠΈΡΡΡΠ³Π°: Π±Π΅Π· ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΠΈ. ΠΠ»Ρ ΡΡΠΎΡΠ½Π΅Π½ΠΈΡ Π΄ΠΈΠ°Π³Π½ΠΎΠ·Π° Π±ΡΠ»ΠΎ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΎ ΠΌΠΎΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ ΡΠΊΠ°Π½Π΅Π²ΡΡ
ΡΡΠ°Π³ΠΌΠ΅Π½ΡΠΎΠ² ΡΠ°Π½Π΅Π²ΠΎΠΉ Π·ΠΎΠ½Ρ, ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΡ ΠΊΠΎΡΠΎΡΠΎΠ³ΠΎ ΡΠ²ΠΈΠ΄Π΅ΡΠ΅Π»ΡΡΡΠ²ΠΎΠ²Π°Π»ΠΈ ΠΎΠ± ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΡΡ
, Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠ½ΡΡ
Π΄Π»Ρ Π³ΠΈΠΏΠ΅ΡΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠ·Π² Π½ΠΈΠΆΠ½ΠΈΡ
ΠΊΠΎΠ½Π΅ΡΠ½ΠΎΡΡΠ΅ΠΉ ΠΈΠ»ΠΈ Π―Π. ΠΡΠΈΠ²Π΅Π΄Π΅Π½Π½ΡΠΉ ΡΠ»ΡΡΠ°ΠΉ ΠΈΠ»Π»ΡΡΡΡΠΈΡΡΠ΅Ρ Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎΡΡΡ ΡΠΈΡΠΎΠΊΠΎΠ³ΠΎ ΠΈΠ½ΡΠΎΡΠΌΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΎΠΉ ΠΎΠ±ΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎΡΡΠΈ ΠΎ Π²Π΅ΡΠΎΡΡΠ½ΠΎΡΡΠΈ Π²ΡΡΡΠ΅ΡΠ°Π΅ΠΌΠΎΡΡΠΈ Π―Π, ΡΡΠΎ, Π² ΡΠ²ΠΎΡ ΠΎΡΠ΅ΡΠ΅Π΄Ρ, ΠΏΡΠ΅Π΄ΠΏΠΎΠ»Π°Π³Π°Π΅Ρ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ Π°Π΄Π΅ΠΊΠ²Π°ΡΠ½ΡΡ
ΠΌΠ΅Ρ ΠΌΠ΅ΡΡΠ½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ, Π²ΠΊΠ»ΡΡΠ°Ρ Π΄Π΅ΡΠΌΠ°ΡΠΎΠΏΠ»Π°ΡΡΠΈΠΊΡ, ΠΈ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΠΉ Π°Π½ΡΠΈΠ³ΠΈΠΏΠ΅ΡΡΠ΅Π½Π·ΠΈΠ²Π½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ
ΠΡΡΡΡΠΉ Π°ΡΡΡΠΈΡ, Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΡΠΉ Ρ COVID-19
Coronavirus infection (COVID-19) is usually characterized by respiratory symptoms, but can have a wide range of clinical manifestations. The growing interest is focusing on the short-term and long-term immune-mediated sequelae triggered by the COVID-19. One of these complications is post-infectious arthritis, classified by some authors as reactive. This paper summarizes and analyzes 25 clinical cases of COVID-19-associated acute arthritis that have been published from January 2020 to November 2021. The mean age of the patients was 46 14 years, with the disease being more prevalent in men than in women. Joint lesions were mono- or polyarticular, with predominant involvement of the joints of the lower extremities. HLA-B27 antigen was determined in 13 of 25 patients and was found in 30% of cases. Like many other viral diseases, the severe acute respiratory syndrome 2 caused by coronavirus can act as a causative agent or a trigger in the development of inflammatory arthritis in predisposed individuals. The post-infectious arthritis should be differentiated from diseases that can manifest with a similar clinical presentation, which requires a complex of laboratory and instrumental studies. Non-steroidal anti-inflammatory drugs and glucocorticosteroids are successfully used in the treatment. The number of cases of post-COVID-19-arthritis is increasing, which urges further studies of its pathophysiology, diagnosis and treatment regimens.ΠΠΎΡΠΎΠ½Π°Π²ΠΈΡΡΡΠ½Π°Ρ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΡ (COVID-19) ΠΎΠ±ΡΡΠ½ΠΎ Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΠ·ΡΠ΅ΡΡΡ ΡΠ΅ΡΠΏΠΈΡΠ°ΡΠΎΡΠ½ΡΠΌΠΈ ΡΠΈΠΌΠΏΡΠΎΠΌΠ°ΠΌΠΈ, ΠΎΠ΄Π½Π°ΠΊΠΎ ΠΌΠΎΠΆΠ΅Ρ ΠΈΠΌΠ΅ΡΡ ΡΠΈΡΠΎΠΊΠΈΠΉ ΡΠΏΠ΅ΠΊΡΡ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΡΠΎΡΠ²Π»Π΅Π½ΠΈΠΉ. Π Π°ΡΡΡΡΠΈΠΉ ΠΈΠ½ΡΠ΅ΡΠ΅Ρ Π²ΡΠ·ΡΠ²Π°ΡΡ ΠΊΡΠ°ΡΠΊΠΎΡΡΠΎΡΠ½ΡΠ΅ ΠΈ Π΄ΠΎΠ»Π³ΠΎΡΡΠΎΡΠ½ΡΠ΅ ΠΈΠΌΠΌΡΠ½ΠΎΠΎΠΏΠΎΡΡΠ΅Π΄ΠΎΠ²Π°Π½Π½ΡΠ΅ ΠΏΠΎΡΠ»Π΅Π΄ΡΡΠ²ΠΈΡ, Π²ΡΠ·Π²Π°Π½Π½ΡΠ΅ COVID-19. ΠΠ΄Π½ΠΎ ΠΈΠ· ΡΠ°ΠΊΠΈΡ
ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΠΉ ΠΏΠΎΡΡΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΎΠ½Π½ΡΠΉ Π°ΡΡΡΠΈΡ, ΠΊΠ»Π°ΡΡΠΈΡΠΈΡΠΈΡΡΠ΅ΠΌΡΠΉ Π½Π΅ΠΊΠΎΡΠΎΡΡΠΌΠΈ Π°Π²ΡΠΎΡΠ°ΠΌΠΈ ΠΊΠ°ΠΊ ΡΠ΅Π°ΠΊΡΠΈΠ²Π½ΡΠΉ. Π ΡΡΠ°ΡΡΠ΅ ΠΎΠ±ΠΎΠ±ΡΠ΅Π½Ρ ΠΈ ΠΏΡΠΎΠ°Π½Π°Π»ΠΈΠ·ΠΈΡΠΎΠ²Π°Π½Ρ ΠΎΠΏΡΠ±Π»ΠΈΠΊΠΎΠ²Π°Π½Π½ΡΠ΅ Π² Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΠ΅ Ρ ΡΠ½Π²Π°ΡΡ 2020 ΠΏΠΎ Π½ΠΎΡΠ±ΡΡ 2021 Π³ΠΎΠ΄Π° 25 ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ
Π½Π°Π±Π»ΡΠ΄Π΅Π½ΠΈΠΉ ΠΎΡΡΡΠΎΠ³ΠΎ Π°ΡΡΡΠΈΡΠ°, Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠ³ΠΎ Ρ COVID-19. Π‘ΡΠ΅Π΄Π½ΠΈΠΉ Π²ΠΎΠ·ΡΠ°ΡΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² ΡΠΎΡΡΠ°Π²ΠΈΠ» 46 14 Π»Π΅Ρ, ΠΏΡΠΈ ΡΡΠΎΠΌ ΠΌΡΠΆΡΠΈΠ½Ρ Π±ΠΎΠ»Π΅Π»ΠΈ ΡΠ°ΡΠ΅, ΡΠ΅ΠΌ ΠΆΠ΅Π½ΡΠΈΠ½Ρ. ΠΠΎΡΠ°ΠΆΠ΅Π½ΠΈΠ΅ ΡΡΡΡΠ°Π²ΠΎΠ² Π±ΡΠ»ΠΎ ΠΌΠΎΠ½ΠΎ- ΠΈΠ»ΠΈ ΠΏΠΎΠ»ΠΈΠ°ΡΡΠΈΠΊΡΠ»ΡΡΠ½ΡΠΌ, Ρ ΠΏΡΠ΅ΠΈΠΌΡΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΠΌ Π²ΠΎΠ²Π»Π΅ΡΠ΅Π½ΠΈΠ΅ΠΌ ΡΡΡΡΠ°Π²ΠΎΠ² Π½ΠΈΠΆΠ½ΠΈΡ
ΠΊΠΎΠ½Π΅ΡΠ½ΠΎΡΡΠ΅ΠΉ. ΠΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ Π°Π½ΡΠΈΠ³Π΅Π½Π° HLA-B27 Π²ΡΠΏΠΎΠ»Π½Π΅Π½ΠΎ Ρ 13 ΠΈΠ· 25 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² ΠΈ Π² 30% ΡΠ»ΡΡΠ°Π΅Π² ΠΏΠΎΠΊΠ°Π·Π°Π»ΠΎ ΠΏΠΎΠ»ΠΎΠΆΠΈΡΠ΅Π»ΡΠ½ΡΠΉ ΡΠ΅Π·ΡΠ»ΡΡΠ°Ρ. ΠΠ°ΠΊ ΠΈ ΠΌΠ½ΠΎΠ³ΠΈΠ΅ Π΄ΡΡΠ³ΠΈΠ΅ Π²ΠΈΡΡΡΠ½ΡΠ΅ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ, ΠΊΠΎΡΠΎΠ½Π°Π²ΠΈΡΡΡ ΡΡΠΆΠ΅Π»ΠΎΠ³ΠΎ ΠΎΡΡΡΠΎΠ³ΠΎ ΡΠ΅ΡΠΏΠΈΡΠ°ΡΠΎΡΠ½ΠΎΠ³ΠΎ ΡΠΈΠ½Π΄ΡΠΎΠΌΠ° 2 ΠΌΠΎΠΆΠ΅Ρ Π²ΡΡΡΡΠΏΠ°ΡΡ Π² ΠΊΠ°ΡΠ΅ΡΡΠ²Π΅ Π²ΠΎΠ·Π±ΡΠ΄ΠΈΡΠ΅Π»Ρ ΠΈΠ»ΠΈ ΡΡΠΈΠ³Π³Π΅ΡΠ° ΡΠ°Π·Π²ΠΈΡΠΈΡ Π²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ Π°ΡΡΡΠΈΡΠ° Ρ ΠΏΡΠ΅Π΄ΡΠ°ΡΠΏΠΎΠ»ΠΎΠΆΠ΅Π½Π½ΡΡ
Π»ΡΠ΄Π΅ΠΉ. Π‘Π»Π΅Π΄ΡΠ΅Ρ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΡΡ Π΄ΠΈΡΡΠ΅ΡΠ΅Π½ΡΠΈΠ°Π»ΡΠ½ΡΡ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΡ ΠΏΠΎΡΡΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΎΠ½Π½ΠΎΠ³ΠΎ Π°ΡΡΡΠΈΡΠ° Ρ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡΠΌΠΈ, ΠΊΠΎΡΠΎΡΡΠ΅ ΠΌΠΎΠ³ΡΡ ΠΏΡΠΎΡΠ²Π»ΡΡΡΡΡ ΡΡ
ΠΎΠΆΠ΅ΠΉ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΊΠ°ΡΡΠΈΠ½ΠΎΠΉ, Π΄Π»Ρ ΡΠ΅Π³ΠΎ Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎ Π²ΡΠΏΠΎΠ»Π½Π΅Π½ΠΈΠ΅ ΠΊΠΎΠΌΠΏΠ»Π΅ΠΊΡΠ° Π»Π°Π±ΠΎΡΠ°ΡΠΎΡΠ½ΡΡ
ΠΈ ΠΈΠ½ΡΡΡΡΠΌΠ΅Π½ΡΠ°Π»ΡΠ½ΡΡ
ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ. ΠΠ»Ρ Π»Π΅ΡΠ΅Π½ΠΈΡ ΡΡΠΏΠ΅ΡΠ½ΠΎ ΠΈΡΠΏΠΎΠ»ΡΠ·ΡΡΡΡΡ Π½Π΅ΡΡΠ΅ΡΠΎΠΈΠ΄Π½ΡΠ΅ ΠΏΡΠΎΡΠΈΠ²ΠΎΠ²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΡΠ΅ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΡ ΠΈ Π³Π»ΡΠΊΠΎΠΊΠΎΡΡΠΈΠΊΠΎΡΡΠ΅ΡΠΎΠΈΠ΄Ρ. Π§ΠΈΡΠ»ΠΎ ΡΠ»ΡΡΠ°Π΅Π² ΠΏΠΎΡΡΠΊΠΎΠ²ΠΈΠ΄Π½ΠΎΠ³ΠΎ Π°ΡΡΡΠΈΡΠ° ΡΠ°ΡΡΠ΅Ρ, ΡΡΠΎ Π΄Π΅Π»Π°Π΅Ρ Π°ΠΊΡΡΠ°Π»ΡΠ½ΡΠΌ Π΄Π°Π»ΡΠ½Π΅ΠΉΡΠ΅Π΅ ΠΈΠ·ΡΡΠ΅Π½ΠΈΠ΅ ΠΏΠ°ΡΠΎΠ³Π΅Π½Π΅Π·Π°, Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ ΠΈ ΡΡ
Π΅ΠΌ Π»Π΅ΡΠ΅Π½ΠΈΡ ΡΡΠΎΠ³ΠΎ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ
Overview of American Heart Association / American College of Cardiology guidelines 2017 for management of patients with valvular heart disease
n June 2017, Circulation journal published updated recommendations of the American Heart Association and the American College of Cardiology (AHA / ACC) on the management of patients with valvular heart disease. The main provisions of this manual are set out in this message. It should be emphasized that the recommendations written by leading US experts in this field are set out clearly, using a variety of tables and figures, which will undoubtedly make them a desktop guide to action for most practitioners in the following years. As usual, when creating such guidelines, the authors were guided by evidence-based methodology using the classes of recommendations and levels of evidence
Myocardial damage in cardioplegia and cardiopulmonary bypass
Cardiopulmonary bypass and cardioplegia are the most frequently used techniques in cardiac surgery. The level of cardiac mortality in the postoperative period depends on them both directly and indirectly. A review of recent data on the pathogenetic mechanisms of myocardial damage in cardioplegia and cardiopulmonary bypass, methods of its diagnosis and basic strategies of myocardial protection is provided